Skip to content
Open access

RAS–Pathway Mutation Profiles and Clinical Outcomes Among Patients With Colorectal Cancer

Oct 2026 · Cancer Medicine · Vol 15 · 0 citations · 45 references
Medicine

Abstract

Somatic alterations in the RAS–RAF–MAPK and PI3K pathways are key in colorectal cancer (CRC), yet their distribution, co‐occurrence patterns, and clinical significance remain incompletely defined. We characterized RAS/MAPK‐ and PI3K‐pathway alterations in a large cohort and assessed their prognostic implications.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.